Northern Trust’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.09M Buy
678,645
+28,218
+4% +$405K ﹤0.01% 2194
2025
Q4
$10M Sell
650,427
-64,377
-9% -$1.18M ﹤0.01% 2084
2025
Q3
$15.5M Buy
714,804
+4,218
+0.6% +$94.1K ﹤0.01% 1861
2025
Q2
$15.8M Sell
710,586
-29,229
-4% -$650K ﹤0.01% 1799
2025
Q1
$17.6M Sell
739,815
-21,975
-3% -$520K ﹤0.01% 1701
2024
Q4
$16.1M Buy
761,790
+15,657
+2% +$411K ﹤0.01% 1836
2024
Q3
$24.1M Buy
746,133
+31,086
+4% +$918K ﹤0.01% 1505
2024
Q2
$17M Sell
715,047
-26,549
-4% -$681K ﹤0.01% 1660
2024
Q1
$22.1M Sell
741,596
-27,323
-4% -$855K ﹤0.01% 1524
2023
Q4
$24.6M Buy
768,919
+84,680
+12% +$2.46M ﹤0.01% 1467
2023
Q3
$20M Sell
684,239
-1,873
-0.3% -$67.3K ﹤0.01% 1539
2023
Q2
$30.9M Buy
686,112
+141,566
+26% +$5.4M 0.01% 1285
2023
Q1
$18.8M Buy
544,546
+23,577
+5% +$765K ﹤0.01% 1595
2022
Q4
$14.5M Buy
520,969
+140,177
+37% +$3.71M ﹤0.01% 1757
2022
Q3
$8.91M Sell
380,792
-913
-0.2% -$29.2K ﹤0.01% 2061
2022
Q2
$11M Buy
381,705
+28,236
+8% +$1.23M ﹤0.01% 1952
2022
Q1
$19.5M Sell
353,469
-12,313
-3% -$609K ﹤0.01% 1700
2021
Q4
$19.5M Buy
365,782
+12,165
+3% +$564K ﹤0.01% 1783
2021
Q3
$15M Sell
353,617
-6,313
-2% -$322K ﹤0.01% 1998
2021
Q2
$24M Buy
359,930
+32,373
+10% +$1.76M ﹤0.01% 1761
2021
Q1
$14.5M Buy
327,557
+10,339
+3% +$384K ﹤0.01% 2044
2020
Q4
$9.2M Sell
317,218
-15,404
-5% -$383K ﹤0.01% 2302
2020
Q3
$7.28M Sell
332,622
-13,616
-4% -$242K ﹤0.01% 2302
2020
Q2
$4.01M Buy
346,238
+41,092
+13% +$450K ﹤0.01% 2647
2020
Q1
$1.99M Buy
305,146
+21,143
+7% +$301K ﹤0.01% 2858
2019
Q4
$4.45M Buy
284,003
+996
+0.4% +$11.3K ﹤0.01% 2657
2019
Q3
$2.09M Buy
283,007
+35,712
+14% +$256K ﹤0.01% 3081
2019
Q2
$2.01M Buy
247,295
+21,761
+10% +$217K ﹤0.01% 3070
2019
Q1
$2.54M Buy
225,534
+11,816
+6% +$149K ﹤0.01% 2930
2018
Q4
$2.09M Sell
213,718
-23,330
-10% -$313K ﹤0.01% 3027
2018
Q3
$3.91M Buy
237,048
+12,517
+6% +$200K ﹤0.01% 2836
2018
Q2
$3.34M Sell
224,531
-6,905
-3% -$116K ﹤0.01% 2928
2018
Q1
$3.97M Sell
231,436
-7,096
-3% -$111K ﹤0.01% 2720
2017
Q4
$2.89M Sell
238,532
-69,143
-22% -$661K ﹤0.01% 2920
2017
Q3
$3.19M Sell
307,675
-63
-0% -$901 ﹤0.01% 2899
2017
Q2
$7M Buy
307,738
+81,468
+36% +$1.68M ﹤0.01% 2408
2017
Q1
$4.41M Buy
226,270
+828
+0.4% +$16.1K ﹤0.01% 2630
2016
Q4
$3.57M Sell
225,442
-12,113
-5% -$201K ﹤0.01% 2764
2016
Q3
$4.81M Buy
237,555
+1,316
+0.6% +$24.2K ﹤0.01% 2542
2016
Q2
$4.23M Buy
236,239
+73,140
+45% +$1.09M ﹤0.01% 2570
2016
Q1
$2.16M Sell
163,099
-12,170
-7% -$188K ﹤0.01% 2939
2015
Q4
$3.59M Buy
+175,269
New +$3.35M ﹤0.01% 2673

Other funds holding SGRY

Northern Trust's SGRY Position: Q1 2026 in Review

Northern Trust increased its Surgery Partners (SGRY) stake by 4.3% in Q1 2026, buying an estimated $405K and bringing the position to 678,645 shares worth $8.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

Northern Trust first reported a position in SGRY in Q4 2015 and has held it in 42 quarters since. The position peaked at $30.9M in Q2 2023. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.

  • Northern Trust held 678,645 shares of Surgery Partners worth $8.09M as of Q1 2026.
  • Northern Trust bought 28,218 Surgery Partners shares in Q1 2026, an estimated $405K.
  • Surgery Partners made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2194 holding.
  • Northern Trust first reported a position in Surgery Partners in Q4 2015 and has held it in 42 quarters since.
  • Northern Trust's Surgery Partners position peaked at $30.9M in Q2 2023.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.